MLEC (Moolec Science) LT-Debt-to-Total-Asset : 0.57 (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Moolec Science LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Moolec Science's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.57.

Moolec Science's long-term debt to total assets ratio increased from Sep. 2023 (0.01) to Sep. 2024 (0.57). It may suggest that Moolec Science is progressively becoming more dependent on debt to grow their business.

Moolec Science LT-Debt-to-Total-Asset Historical Data

The historical data trend for Moolec Science's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moolec Science LT-Debt-to-Total-Asset Chart

Moolec Science Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

LT-Debt-to-Total-Asset

0.34

Moolec Science Quarterly Data
	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial								0.01	0.28	0.42	0.34	0.57

Moolec Science LT-Debt-to-Total-Asset Calculation

Moolec Science's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (A: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2024 )	/	Total Assets (A: Jun. 2024 )
	=	11.952	/	34.787
	=	0.34

Moolec Science's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	18.432	/	32.558
	=	0.57

Moolec Science (NAS:MLEC) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Moolec Science LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Moolec Science's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Moolec Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moolec Science SA (NAS:MLEC) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

17, Boulevard F.W. Raiffeisen, Luxembourg, LUX, L-2411

Website

https://www.moolecscience.com

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.